Henry Schein Inc. (NASDAQ:HSIC) reported stronger-than-expected earnings for the fourth quarter. The Melville, New York-based company posted quarterly earnings of $133 million, or $1.56 per share, compared to $124 million, or $1.43 per share, in the year-ago period. On Wednesday shares of Henry Schein, Inc. (NASDAQ:HSIC) closed at $141.99. Company’s sales growth for last 5 years was 8.40% and EPS growth for next 5 years is recorded as 11.00%.
On 9 February, Comstock Resources Inc. (NYSE:CRK) reported a loss from continuing operations of $55.1 million or $1.19 per share for the three months ended December 31, 2014 as compared to a loss from continuing operations of $36.6 million or 80¢ per share for the three months ended December 31, 2013. Comstock Resources Inc. (NYSE:CRK) in last trading activity increased 6.34% to close at $5.37. Company weekly performance is -2.19% while its quarterly performance stands at -51.53%. Comstock Resources Inc. (NYSE:CRK) is -81.40% away from its 52 week high.
On 3 February, Eaton Corporation plc (NYSE:ETN) announced operating earnings per share for the fourth quarter of $1.27, which exclude charges of $0.04 per share to integrate recent acquisitions, an increase of 18 percent over the fourth quarter of 2013. Sales in the quarter were $5.6 billion, up 1 percent over the same period in 2013. On last trading day Eaton Corporation plc (NYSE:ETN) moved down -0.58% to close at $70.33. Its volatility for the week is 1.58% while volatility for the month is 2.11%. ETN’s sales growth for past 5 years was 13.70% and its EPS growth for past 5 years was 27.00%. Eaton Corporation plc (NYSE:ETN) monthly performance is 7.41%.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) said it found some business practices and transactions could violate the U.S. Foreign Corrupt Practices Act. Teva Pharmaceutical Industries Limited (NYSE:TEVA) institutional ownership stands at 54.40%. In last trading activity company’s stock closed at $56.88.
Edwards Lifesciences Corporation (NYSE: EW), announced two changes to the company’s board of directors. Kieran T. Gallahue, chairman and chief executive officer of CareFusion Corporation, has been appointed to Edwards’ board, effective immediately. Current director Mike R. Bowlin has expressed his desire to retire from the board and will not seek re-election at the annual stockholder meeting in May. On last trading day Edwards Lifesciences Corp. (NYSE:EW) increased 1.17% to close at $131.59. Its volatility for the week is 2.53% while volatility for the month is 2.52%. EW’s sales growth for past 5 years was 10.60% and its EPS growth for past 5 years was 25.60%. Edwards Lifesciences Corp. (NYSE:EW) monthly performance is -2.73%.